CAR-T cell therapy researchImmunotherapy and Immune ResponsesCutaneous lymphoproliferative disorders research

M. Barden, D. C. Harrer, H. Abken

2026.1.1Critical Reviews in Oncogenesis

DOI: 10.1615/critrevoncog.2026063886

Abstract

Abstract is not available.

Citation format

BARDEN, M.; HARRER, D. C.; ABKEN, H. Does CAR t cell therapy of solid cancer need the activation of an innate immune response? Critical Reviews in Oncogenesis, 2026.